A rare lymphoma in a patient with amyopathic dermatomyositis

American Journal of Clinical Dermatology

Volumn 11, Issue 2, 2010, Pages 151-155

  Ledwich, Lindsay J ^a   Olenginski, Thomas P ^a  

^a GEISINGER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOBETASOL; CYCLOPHOSPHAMIDE; DESONIDE; DOXORUBICIN; FOLIC ACID; HYDROXYCHLOROQUINE; METHOTREXATE; METHYLPREDNISOLONE; RITUXIMAB; VINCRISTINE;

ABDOMINAL HYSTERECTOMY; ADULT; AMYOPATHIC DERMATOMYOSITIS; ARTICLE; CANCER RADIOTHERAPY; CASE REPORT; CENTRAL NERVOUS SYSTEM DISEASE; DERMATOMYOSITIS; DRUG MEGADOSE; FEMALE; HUMAN; MULTIPLE CYCLE TREATMENT; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RASH; SKIN BIOPSY;

ADULT; DERMATOMYOSITIS; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, CUTANEOUS; LYMPHOMA, B-CELL; UTERINE CERVICAL NEOPLASMS;

EID: 77949406293     PISSN: 11750561     EISSN: 11791888     Source Type: Journal    
DOI: 10.2165/11530170-000000000-00000     Document Type: Article

References (23)

1. Sigurgeirsson B, Lindelof B, Edhad O, et al. Risk of cancer in patients with dermatomyositis or polymyositis. N Engl J Med 1992; 326 (6): 363-367
2. Lakhanpal S, Bunch TW, Ilstrup DM, et al. Polymyositis-dermatomyositis and malignant lesions: does an association exist? Mayo Clin Proc 1986; 61: 645-653
3. Manchul LA, Jin A, Pritchard K, et al. The frequency of malignant neoplasms in patients with polymyositis-dermatomyositis. Arch Intern Med 1985; 145: 1835-1839
4. Buchbiner R, Forbes A, Hall S, et al. Incidence of malignant disease in biopsyproven inflammatory myopathy. Ann Intern Med 2001; 134: 1087-1095
5. Callen J. Relationship of cancer to inflammatory muscle diseases. Rheum Dis Clin North Am 1994; 20 (4): 943-953
6. Callen J. When and how should the patient with dermatomyositis or amyopathic dermatomyositis be assessed for possible cancer? Arch Dermatol 2002; 138 (7): 969-971
7. Whitmore SE, Reosenshien NB, Provost TT. Ovarian cancer in patients with dermatomyositis. Medicine 1994; 73: 153-160
8. Sparsa A, Ciozon E, Herrmann F, et al. Routine vs extensive malignancy search for adult dermatomyositis and polymyositis. Arch Dermatol 2002; 138: 885-890
9. Euwer R, Sontheimer R. Amyopathic dermatomyositis (dermatomyositis sine myositis): presentation of six new cases and review of the literature. J Am Acad Dermatol 2002; 24 (6 Pt 1): 959-966
10. Sontheimer RD. Dermatomyositis: an overview of recent progress with emphasis on dermatologic aspects. Dermatol Clin 2002; 20 (3): 387-408
11. Yazici Y, Kagen L. The association of malignancy with myositis. Curr Opin Rheumatol 2000; 12 (6): 498-500
12. Parodi A, Caproni M, Marzano AV, et al. Dermatomyositis in 132 patients with different clinical subtypes: cutaneous signs, constitutional symptoms, and circulating antibodies. Acta Derm Venereol 2002; 82: 48-51
13. Hunger R, Durr C, Brand CU. Cutaneous leukocytoclastic vasculitis in dermatomyositis suggests malignancy. Dermatology 2001; 202: 123-156
14. Olsen NJ, Park JH, King LE. Amyopathic dermatomyositis. J Am Acad Dermatol 2001; 3: 346-351
15. el-Azhary RA, Pakzad SY. Amyopathic dermatomyositis: retrospective review of 37 cases. Int J Dermatol 2002; 46 (4): L560-5
16. Cosnes A, Amaudric F, Gherardi R, et al. Dermatomyositis without muscle weakness. Clin Rheumatol 1995; 131: 1381-1385
17. Finger DR, Dunn CL, Gilliland WR, et al. Amyopathic dermatomyositis associated with malignancy. Int J Dermatol 1996; 35 (9): 663-664
18. Celebi S, Gul A, Kamali S, et al. Amyopathic dermatomyositis associated with cervical cancer. Clin Rheumatol 2001; 20: 438-440
19. Chan JK, Loizzi V, Magistris A, et al. Clinicopathologic features of six cases of primary cervical lymphoma. Am J Obstet Gynecol 2005; 193 (3): 866-872
20. Feng W, Cohen JI, Fischer S, et al. Reactivation of latent Epstein-Barr virus by methotrexate: a potential contributor to methotrexate-associated lympho-mas. J Natl Cancer Inst 2004; 96 (22): 1691-1702
21. Waldman MA, Callen JP. Self-resolution of Epstein-Barr virus-associated B-cell lymphoma in a patient with dermatomyositis following withdrawal of mycophenolate mofetil and methotrexate. J. Am Acad Dermatol 2004; 51 (2 Suppl.): S124-30
22. Venables PJW, Mumford PA, Maini RN. Antibodies to nuclear antigens in polymyositis: relationship to autoimmune 'overlap syndromes' and carcinoma. Ann Rheum Dis 1981; 40: 217-223
23. Solans-Laque R, Perex-Bocanegra C, Salud-Salvia A, et al. Clinical significance of antinuclear antibodies in malignant disease: association with rheumatic and connective tissue paraneoplastic syndromes. Lupus 2004; 13 (3): 159-164